Pegasus spyware, initially targeting journalists, now targets corporate executives, with 11 new infections detected among 18,000 devices globally. Developed by NSO Group, it utilizes zero-click exploits for stealthy infiltration. iVerify’s detection tools highlight the spyware’s adaptability, as many victims remain unaware. Ongoing collaboration and proactive monitoring are essential for mitigating risks in this evolving espionage landscape.
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity
Bluebird Bio, a biotech company with three approved gene therapies but no way of commercialising them, will be sold to private equity firms Carlyle and
